Atul Pande
6 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 6 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $108K | Nov 11SEC filing | |
| Sell(10b5-1 plan) | $65K | Aug 28SEC filing | |
| Sell(10b5-1 plan) | $60K | Jul 24SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Atul Pande's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 6 |
Alerts for Atul Pande
Use this page
How to cite
Breakaway, Atul Pande: Director at Immunovant (IMVT), insider trades, Nov 12, 2026, getbreakaway.com/insiders/atul-pande
Journalists: email support@getbreakaway.com for the data behind this page.